CompletedNCT00877292

A New Prenatal Blood Test for Down Syndrome

Studying Down syndrome

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Women and Infants Hospital of Rhode Island
Principal Investigator: Barbara O'Brien, MD
Women and Infants Hospital
Enrollment: 4664 enrolled
Eligibility: 18 years · FEMALE
Timeline: 2009 – 2011

Study locations (27)

University of Alabama at Birmingham, Birmingham, Alabama, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
Yale University School of Medicine, New Haven, Connecticut, United States
Northwestern University, FSM, Chicago, Illinois, United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Henry Ford Hospital, Detroit, Michigan, United States
New Beginnings Perinatal Consultants, Providence, Rhode Island, United States
Women and Infants Hospital, Providence, Rhode Island, United States
Baylor College of Medicine, Houston, Texas, United States
Intermountain Health Care, Murray, Utah, United States
UVA Medical Center, Charlottesville, Virginia, United States
Center for Medical Education and Clinical Investiagtion, Buenos Aires, Argentina
Sociedad Italiana de Beneficencia en Buenos Aires - Hospital Italiano, Buenos Aires, Argentina
University of Sydney, St Leonards, New South Wales, Australia
+12 more locations on ClinicalTrials.gov

Collaborators

Sequenom, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00877292 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome →

← Back to all trials